ApprovalTrail

Approval · Notice of Compliance 31025 · 2023

DOMIDINE: Notice of Compliance 31025

Issued June 21, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
31025
Date
June 21, 2023
Product type
Veterinary
Submission
Supplement to an Abbreviated New Drug Submission (SANDS), supplement
Submission class
Other
Reason
Manufacturing changes for drug product
Canadian reference product
DORMOSEDAN (Orion Corporation)

Products in this notice

BrandDINStatus today
DOMIDINE02485303Marketed

Medicinal ingredients